ENT Support

Product NDC

43742-2142

11-digit product format

437422142

Labeler code

43742

Product ID

43742-2142_1048b4f7-bc6b-42da-8c6e-ae5e11f3299e

Type

HUMAN OTC DRUG

Nonproprietary name

Argentum Nitricum, Aspergillus Niger, Candida Albicans, Euphorbium Officinarum, Gallicum Acidum, Hepar Sulphuris Calcareum, Influenzinum (2023-2024), Luffa Operculata, Mercurius Iodatus Ruber, Mucor Racemosus, Mutabile Bacillus (Bach), Pulsatilla (Pratensis), Sinusitisinum

Dosage form

LIQUID

Route

ORAL

Labeler

Deseret Biologicals, Inc.

Marketing category

UNAPPROVED HOMEOPATHIC

Marketing start

2024-03-13

Marketing end

2029-05-17

Substance

ASPERGILLUS NIGER VAR. NIGER; CALCIUM SULFIDE; CANDIDA ALBICANS; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; GALLIC ACID MONOHYDRATE; INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE; INFLUENZA A VIRUS WHOLE; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; LUFFA OPERCULATA FRUIT; MERCURIC IODIDE; MUCOR RACEMOSUS; PULSATILLA PRATENSIS WHOLE; SILVER NITRATE; SINUSITISINUM

Active strength

10; 10; 10; 30; 6; 10; 12; 12; 12; 12; 6; 8; 10; 4; 10; 17 [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL

Pharmacologic classes

Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]

NDC exclude flag

No

Current FDA listing

Yes